Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine

NCT01696422 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: Dengue 1,2,3,4 (attenuated) vaccine
BIOLOGICAL: TetraVax-DV Vaccine - Admixture TV003
OTHER: Placebo

Sponsor

Butantan Institute

Collaborators

[object Object]
[object Object]
[object Object]